Europe PMCopen access
Targeted Nanoparticle Delivery CRISPR/Cas9: overcoming biological barriers, enhancing stability, and improving therapeutic precision
Gene therapy, Targeted Delivery, Crispr/cas9, Stimuli-responsive Nanoparticle, Surface-modified Nanoparticle
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 780679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.